These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27743572)

  • 1. Postloco-Regional Therapy Imaging of the Liver.
    Kwok N; Lee SR; Arellano RS
    Semin Roentgenol; 2016 Oct; 51(4):378-383. PubMed ID: 27743572
    [No Abstract]   [Full Text] [Related]  

  • 2. The current role of minimally invasive therapies in the management of liver tumors.
    Rempp H; Boss A; Helmberger T; Pereira P
    Abdom Imaging; 2011 Dec; 36(6):635-47. PubMed ID: 21562884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic Resonance Imaging Findings After Percutaneous Irreversible Electroporation of Liver Metastases: A Systematic Longitudinal Study.
    Barabasch A; Distelmaier M; Heil P; Krämer NA; Kuhl CK; Bruners P
    Invest Radiol; 2017 Jan; 52(1):23-29. PubMed ID: 27379698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible electroporation for the ablation of liver tumors: are we there yet?
    Charpentier KP
    Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of the Liver Following Interventional Therapy for Hepatic Neoplasms.
    Adam SZ; Miller FH
    Radiol Clin North Am; 2015 Sep; 53(5):1061-76. PubMed ID: 26321454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
    Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
    PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible electroporation ablation of the liver can be detected with ultrasound B-mode and elastography.
    Au JT; Kingham TP; Jun K; Haddad D; Gholami S; Mojica K; Monette S; Ezell P; Fong Y
    Surgery; 2013 Jun; 153(6):787-93. PubMed ID: 23489942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.
    Dollinger M; Beyer LP; Haimerl M; Niessen C; Jung EM; Zeman F; Stroszczynski C; Wiggermann P
    Diagn Interv Radiol; 2015; 21(6):471-5. PubMed ID: 26359870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ablation of a liver metastasis with irreversible electroporation (IRE) in liver segment II adjoining the area nuda].
    Niessen C; Jung EM; Stroszczynski C; Wiggermann P
    Rofo; 2012 Oct; 184(10):937-8. PubMed ID: 22744330
    [No Abstract]   [Full Text] [Related]  

  • 10. MR-Guided Liver Interventions.
    Weiss J; Hoffmann R; Clasen S
    Top Magn Reson Imaging; 2018 Jun; 27(3):163-170. PubMed ID: 29870468
    [No Abstract]   [Full Text] [Related]  

  • 11. Contrast Enhancement Patterns after Irreversible Electroporation: Experimental Study of CT Perfusion Correlated to Histopathology in Normal Porcine Liver.
    Chung DJ; Sung K; Osuagwu FC; Wu HH; Lassman C; Lu DS
    J Vasc Interv Radiol; 2016 Jan; 27(1):104-11. PubMed ID: 26547121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Needle Tract Seeding Following Irreversible Electroporation (IRE) of Metastatic Colorectal Carcinoma to the Liver.
    Fredericks C; Arslan B; Mullane M; Firfer BL; Chan EY
    Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1349-51. PubMed ID: 25986464
    [No Abstract]   [Full Text] [Related]  

  • 13. Computed Tomography-Guided Tumor Ablation: Analysis and Optimization of Computed Tomography Technique With Various Ablation Devices.
    Eltorai AE; Baird GL; Monu N; Bialo D; Collins S; Kim JS; Dupuy DE
    J Comput Assist Tomogr; 2017; 41(2):279-283. PubMed ID: 27824668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anesthesia for irreversible electroporation of hepatic malignant tumors.
    Trabold B; Wiggermann P; Akyol D; Jung EM; Nießen C; Stroszczynski C; Graf BM; Wiese C
    J Clin Anesth; 2013 Aug; 25(5):430-431. PubMed ID: 23965203
    [No Abstract]   [Full Text] [Related]  

  • 15. Imaging appearances at follow-up after image-guided solid-organ abdominal tumour ablation.
    Patel N; King AJ; Breen DJ
    Clin Radiol; 2017 Aug; 72(8):680-690. PubMed ID: 28237299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally invasive therapies for hepatic malignancy.
    Knab LM; Salem R; Mahvi DM
    Curr Probl Surg; 2013 Apr; 50(4):146-79. PubMed ID: 23507316
    [No Abstract]   [Full Text] [Related]  

  • 17. Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma.
    Allgaier HP; Deibert P; Zuber I; Olschewski M; Blum HE
    Lancet; 1999 May; 353(9165):1676-7. PubMed ID: 10335793
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of in vivo ablation zones following percutaneous microwave ablation of the liver with two commercially available devices: are manufacturer published reference values useful?
    Winokur RS; Du JY; Pua BB; Talenfeld AD; Sista AK; Schiffman MA; Trost DW; Madoff DC
    J Vasc Interv Radiol; 2014 Dec; 25(12):1939-1946.e1. PubMed ID: 25307296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Navigation Systems for Treatment Planning and Execution of Percutaneous Irreversible Electroporation.
    Fuhrmann I; Probst U; Wiggermann P; Beyer L
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818791792. PubMed ID: 30071779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging after local tumor therapies: kidney and liver.
    Kielar AZ; Hibbert RM; Maturen KE
    Semin Roentgenol; 2013 Jul; 48(3):273-84. PubMed ID: 23796378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.